IP Library Granted Patent US 9,114,151
Granted Patent B2
US 9,114,151 · App. 12/929,786 · Granted Aug 25, 2015

Method for modulating or controlling sodium channel current by reactive oxygen species (ROS) originating from mitochondria

Inventor: Samuel C. Dudley, Jr. (Chicago, IL)
Assignees: THE UNITED STATES OF AMERICA DEPT. OF VETERANS AFFAIRS; THE BOARD OF TRUSTEES OF THE UNIV. OF ILLINOIS
A61K31/7084A61K31/194A61K31/35
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,114,151
App. No.
12/929,786
Granted
Aug 25, 2015
Kind
B2
Abstract

Method for modulating or controlling sodium channel current of a cell includes inducing mitochondrial reactive oxygen species (ROS) production in the cell.

Claims (10)

1. A method of reducing arrhythmic risk in an individual with elevated intracellular NADH level, comprising the steps of:

a) providing an individual with elevated intracellular NADH level;

b) lowering the intracellular NADH level to a predetermined normal level by administering to the individual a therapeutic amount of a mitochondrial targeted antioxidant; and

c) wherein achieving the normal intracellular NADH level reduces arrhythmic risk in the individual.

2. The method of claim 1 , wherein the amount of antioxidant is effective to reduce arrhythmic risk.

3. The method of claim 1 , wherein the antioxidant prevents reduction in sodium channel current (I Na ) by reducing or suppressing mitochondrial ROS production.

4. The method of claim 1 , wherein the antioxidant is administered orally or intravenously.

5. The method of claim 1 , wherein the individual is suffering from arrhythmia.

6. The method of claim 1 , wherein the antioxidant comprises at least one member selected from the group consisting of a powder, a tablet, a capsule, a solution, a suspension, and an injectable formulation.

7. The method of claim 1 , wherein the antioxidant prevents a change in sodium channel current (I Na ) by reducing or suppressing mitochondrial ROS production.

Assignments (2)
CONFIRMATORY LICENSE Recorded Mar 16, 2011
From: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS ON BEHALF OF ITS OFFICE OF TECHNOLOGY MANAGEMENT OFFICE AT THE UNIVERSITY OF ILLINOIS AT CHICAGO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 025958/0885 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2011
From: DUDLEY, SAMUEL C, JR
To: U.S. DEPARTMENT OF VETERANS AFFAIRS; BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS, THE
Reel/Frame 025865/0704 →
Continuity (4)
Continuation In Part 12289005 · Oct 17, 2008
Provisional Application 60960883 · Oct 18, 2007
Provisional Application 61305668 · Feb 18, 2010
Related Publication 20110144192A1 · Jun 16, 2011